These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2569409)

  • 21. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD; Glock D; Goldberg LI
    J Pharm Pharmacol; 1986 May; 38(5):401-2. PubMed ID: 2872323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
    Montier F; Katchadourian P; Pratz J; Cavero I
    J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
    Goldberg LI; Glock D; Kohli JD; Barnett A
    Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
    Horn PT; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of adrenal catecholamine release by DA2 dopamine receptors in the anaesthetized dog.
    Foucart S; Lacaille-Belanger P; Kimura T; Nadeau R; de Champlain J
    Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):601-11. PubMed ID: 2908435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia.
    Mukai M; Kushiku K; Yamada H; Yamada K; Dan K; Furukawa T
    J Pharmacol Exp Ther; 1996 Nov; 279(2):822-9. PubMed ID: 8930189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prejunctional adrenoceptor activity of N-0437: a relatively selective DA2 dopamine receptor agonist.
    Crosson CE; Burke JA; Chan MF; Potter DE
    Eur J Pharmacol; 1990 Mar; 178(3):351-5. PubMed ID: 1971223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1985 Aug; 114(3):305-10. PubMed ID: 4065203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
    Nishiyama S; Yoshikawa M; Yamaguchi I
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral dopamine receptors.
    Kohli JD
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):25S-28S. PubMed ID: 2143385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enkephalin modulation of neural transmission in the cat stellate ganglion: pharmacological actions of exogenous opiates.
    Prosdocimi M; Finesso M; Gorio A
    J Auton Nerv Syst; 1986 Nov; 17(3):217-30. PubMed ID: 2432108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.